Get the Stockscreener App
6.54
0.46%
0.03
Aura Biosciences Inc stock is traded at $6.54, with a volume of 155.90K.
It is up +0.46% in the last 24 hours and up +17.41% over the past month.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
See More
Previous Close:
$6.51
Open:
$6.5
24h Volume:
155.90K
Relative Volume:
0.61
Market Cap:
$415.31M
Revenue:
-
Net Income/Loss:
$-76.41M
P/E Ratio:
-3.4063
EPS:
-1.92
Net Cash Flow:
$-64.56M
1W Performance:
+1.71%
1M Performance:
+17.41%
6M Performance:
-1.95%
1Y Performance:
-22.51%
1-Day Range:
$6.465
$6.69
1-Week Range:
$6.27
$6.69
52-Week Range:
$4.345
$9.04
Aura Biosciences Inc Stock (AURA) Company Profile
Name
Aura Biosciences Inc
Sector
Industry
Phone
(617)500-8864
Address
80 GUEST STREET, BOSTON
Compare AURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
6.54 | 413.41M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-26-25 | Resumed | Evercore ISI | Outperform |
| May-28-25 | Resumed | H.C. Wainwright | Buy |
| Jul-25-24 | Initiated | H.C. Wainwright | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Outperform |
| Apr-17-23 | Resumed | BTIG Research | Buy |
| Jul-19-22 | Initiated | JMP Securities | Mkt Outperform |
View All
Aura Biosciences Inc Stock (AURA) Latest News
Aura Biosciences, Inc. $AURA Stock Position Increased by B Group Inc. - Defense World
(AURA) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Rally Mode: Why Aura Biosciences Inc stock is trending among retail tradersEarnings Performance Report & Capital Efficiency Focused Strategies - moha.gov.vn
Weekly Recap: Will BWMN stock beat EPS estimatesQuarterly Profit Review & Momentum Based Trading Ideas - BỘ NỘI VỤ
Why Aura Biosciences Inc. stock is trending among retail tradersWeekly Risk Summary & Precise Swing Trade Alerts - Newser
Can Aura Biosciences Inc. stock outperform in 2025 bull marketWeekly Stock Recap & Daily Profit Maximizing Tips - Newser
Aura Biosciences (AURA) Stock Analysis Report | Financials & Insights - Benzinga
Aura Biosciences re-initiated with an Outperform at Evercore ISI - MSN
Market Pulse: Can Aura Biosciences Inc. stock continue upward trendPortfolio Gains Summary & AI Powered Buy and Sell Recommendations - moha.gov.vn
Evercore ISI Group Reiterates Aura Biosciences (AURA) Outperform Recommendation - MSN
What drives Aura Biosciences Inc stock priceStock Buyback Announcements & Double Or Triple Wealth - earlytimes.in
Avenzo adds CFO responsibilities to CBO Lipman’s role - BioCentury
(AURA) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
AURA Stock Receives an "Outperform" Rating from Evercore ISI Gro - GuruFocus
Is Aura Biosciences (NASDAQ:AURA) In A Good Position To Deliver On Growth Plans? - Sahm
Evercore ISI resumes Aura Biosciences stock coverage with Outperform rating By Investing.com - Investing.com Canada
Innovative Approach and Promising Data Drive Buy Rating for Aura Biosciences - TipRanks
Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times
Aura Biosciences (NASDAQ: AURA) CEO Fireside Chat at Evercore Healthcare Conf. 2025 - Stock Titan
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
How Aura Biosciences Inc. stock performs during Fed tightening cyclesJuly 2025 Review & Weekly High Potential Alerts - newser.com
NovaBridge subsidiary Visara appoints two key ophthalmology leaders By Investing.com - Investing.com Canada
Is Aura Biosciences Inc. stock attractive for growth ETFsEarnings Growth Report & Free Expert Verified Stock Movement Alerts - newser.com
Leerink Partnrs Has Positive Outlook of AURA FY2025 Earnings - Defense World
Aura Biosciences Inc. stock trend forecastJuly 2025 Price Swings & Consistent Growth Equity Picks - newser.com
Aura Biosciences Inc. stock outlook for YEARBuy Signal & Low Risk High Reward Ideas - newser.com
What sentiment indicators say about Aura Biosciences Inc. stockGap Down & Weekly Market Pulse Updates - newser.com
Is it time to cut losses on Aura Biosciences Inc.2025 Technical Patterns & Growth Focused Stock Pick Reports - newser.com
Why Aura Biosciences Inc. stock could see breakout soonPortfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
Top Executive Makes Bold Move with Aura Biosciences Stock Sale! - TipRanks
Officer Hopkins Files To Sell 17,109 Of Aura Biosciences Inc [AURA] - TradingView
Aura Biosciences CMO Sells Shares to Cover Tax Obligations - TradingView
Officer Hopkins Surrenders 17,109 Of Aura Biosciences Inc [AURA] - TradingView
[Form 4] Aura Biosciences, Inc. Insider Trading Activity - Stock Titan
What is HC Wainwright’s Estimate for AURA Q1 Earnings? - Defense World
Volume spikes in Aura Biosciences Inc. stock – what they meanQuarterly Profit Report & Fast Entry Momentum Trade Alerts - newser.com
Published on: 2025-11-16 12:54:55 - newser.com
Using fundamentals and technicals on Aura Biosciences Inc.Trade Exit Report & Growth Focused Entry Reports - newser.com
Is Aura Biosciences Inc. stock cheap compared to fundamentalsJuly 2025 WrapUp & Risk Adjusted Swing Trade Ideas - newser.com
How Aura Biosciences Inc. stock performs in weak economyJuly 2025 Fed Impact & Free Community Supported Trade Ideas - newser.com
(AURA) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Aura Biosciences Inc Stock (AURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):